SYS-CON MEDIA Authors: Doug Masi, Mat Mathews, PR.com Newswire, David Smith, Tim Crawford

News Feed Item

Aemetis, Inc. Reports Second Quarter 2014 Results

CUPERTINO, CA -- (Marketwired) -- 08/07/14 -- Aemetis, Inc. (NASDAQ: AMTX)

  • Paid down $13.6 million in debt (principal and interest)
  • Quarterly adjusted EBITDA of $9.1 million
  • Quarterly operating income of $7.8 million
  • Net income of $2.7 million or $0.13 per share
  • Revenues of $57.2 million
  • Cash and cash equivalents of $4.8 million at June 30, 2014

Aemetis, Inc. (NASDAQ: AMTX), an advanced renewable fuels and biochemicals company, today announced its financial results for the three-and-six months ended June 30, 2014.

"We are pleased with the Company's continued positive financial performance and strong second quarter," said Eric McAfee, Chairman and CEO of Aemetis, Inc. "Aemetis achieved significant milestones during Q2, including a NASDAQ listing, completion of the EPA process for importation of our India biodiesel into the US, and our first distilled biodiesel shipment to Europe from our India plant under the newly awarded ISCC certification," added McAfee.

Financial Results for the Three Months Ended June 30, 2014

For the second quarter, revenue was $57.2 million, a 21% increase over the same quarter in 2013. Gross profit was $11.4 million, a 203% increase over the second quarter of 2013 gross profit of $3.8 million. The increase in revenue between the three months ended June 30, 2014 and 2013 reflects the period from April 1, 2013 to April 23, 2013 when the Keyes plant was idle, compared to a full quarter of operation for the quarter ended June 30, 2014.

Operating income for the second quarter of 2014 was $7.8 million, compared to an operating loss of $0.4 million for the same period in 2013.

Interest rate expense of $2.5 million was a reduction of 13% compared to $2.9 million for the second quarter of 2013, reflecting a reduction in the principal outstanding. Fee amortization expense of $2.5 million was 59% less in the second quarter of 2014 than the second quarter of 2013 charge of $6.1 million.

Net Income for the second quarter of 2014 was $2.7 million or $0.13 per share compared to a loss of $9.6 million for the second quarter of 2013.

Strong cash flow resulted in Cash and Cash Equivalents of $4.8 million as of June 30, 2014 and allowed for principal and interest payments on term debt of approximately $13.6 million during the second quarter of 2014.

Financial Results for the Six Months Ended June 30, 2014

Revenue for the six months ended June 30, 2014 was $117.9 million, compared to $66.8 million during the same period of 2013. The increase in revenue reflects a strong margin environment in the first half of 2014, and is also partially attributable to the idling of the Keyes ethanol plant for approximately three months from late January through late April 2013.

Gross profit was a record $27.0 million compared to $4.0 million during the same period of 2013.

Net income was $10.4 million or $0.49 per diluted share compared to a net loss of $19.4 million or $1.04 loss per diluted share during the same period of 2013.

Adjusted EBITDA for the six months ended June 30, 2014 was a record $23.3 million compared to a negative $1.1 million for the same period of 2013.

Non-GAAP Financial Information

We have provided non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data. Adjusted EBITDA is defined as net income/(loss) plus (to the extent deducted in calculating such net income) interest expense, income tax expense, intangible and other amortization expense, depreciation expense, and share-based compensation expense.

Adjusted EBITDA is not calculated in accordance with GAAP and should not be considered as an alternative to net income/(loss), operating income or any other performance measures derived in accordance with GAAP or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA is presented solely as a supplemental disclosure because management believes that it is a useful performance measure that is widely used within the industry in which we operate. In addition, management uses Adjusted EBITDA for reviewing financial results and for budgeting and planning purposes. EBITDA measures are not calculated in the same manner by all companies and, accordingly, may not be an appropriate measure for comparison.

Safe Harbor Statement

This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this news release include, without limitation, statements regarding our possible importation of biofuels from our India plant into the U.S. and continued shipments of biodiesel into Europe. Words or phrases such as "anticipates," "may," "will," "should," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "targets," "will likely result," "will continue" or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, counter-party risks, risks associated with changes to federal policy or regulation, risks associated with the conversion of the Keyes plant to the use of sorghum for ethanol production; and other risks detailed in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2013, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2014, our Quarterly Report on Form 10-Q for the quarter ended June 30, 2014 and in our subsequent filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.

About Aemetis

Headquartered in Cupertino, California, Aemetis is an advanced fuels and renewable chemicals company founded in 2006. Aemetis owns and operates a 60 million gallon capacity ethanol and 420,000 ton animal feed plant in California that is the first US facility approved by the EPA to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. Aemetis also built, owns, and operates a 50 million gallon capacity renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds five granted patents on its Z-microbe and related technology for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit aemetis.com.

(Tables follow)



                               AEMETIS, INC.
              CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
              (unaudited, in thousands except per share data)

                                     Three months ended   Six months ended
                                           June 30             June 30
                                     ------------------  ------------------
  (in thousands, except per share)     2014      2013      2014      2013
                                     --------  --------  --------  --------
Revenues                             $ 57,195  $ 47,353  $117,860  $ 66,773
Cost of goods sold                     45,842    43,602    90,883    62,775
                                     --------  --------  --------  --------
Gross profit                           11,353     3,751    26,977     3,998

Research and development expenses         141       124       241       353
Selling, general and administrative
 expenses                               3,449     3,984     6,291     8,199
                                     --------  --------  --------  --------
Operating income/(loss)                 7,763      (357)   20,445    (4,554)

Interest rate expense                  (2,530)   (2,913)   (5,450)   (5,583)
Amortization expense                   (2,502)   (6,072)   (4,620)   (8,346)
Loss on debt extinguishment                 -      (231)     (115)   (1,188)
Other income/(expense)                     (9)      (20)      155       271
                                     --------  --------  --------  --------
Income/(loss) before income taxes       2,722    (9,593)   10,415   (19,400)

Income tax expense                          -         -        (6)       (6)

                                     --------  --------  --------  --------
Net income/(loss)                    $  2,722  $ (9,593) $ 10,409  $(19,406)
                                     ========  ========  ========  ========

Net Income/(loss) per common share*
 Basic                               $   0.13  $  (0.51) $   0.52  $  (1.04)
 Diluted                             $   0.13  $  (0.51) $   0.49  $  (1.04)

Weighted average shares outstanding*
 Basic                                 20,284    18,964    20,146    18,596
 Diluted                               20,948    18,964    21,299    18,596

* The Earnings per share and Weighted average shares outstanding for all
 periods presented reflect the one-for-ten reverse split, which took effect
 May 15, 2014.




                               AEMETIS, INC.
                   CONSOLIDATED CONDENSED BALANCE SHEETS
                         (unaudited, in thousands)

                                                  June 30,     December 31,
                                                    2014           2013
                                                ------------  -------------
Assets
Current assets:
  Cash and cash equivalents                     $      4,780  $       4,926
  Accounts receivable                                    828          2,764
  Inventories                                          5,052          4,098
  Prepaid expenses and Other current assets            2,111            919
                                                ------------  -------------
Total current assets                                  12,771         12,707

Property, plant and equipment, Net                    77,180         78,928
Goodwill, Intangibles and Other assets                 5,496          5,507
                                                ------------  -------------
Total assets                                    $     95,447  $      97,142
                                                ============  =============

Liabilities and stockholders' deficit
Current liabilities:
  Accounts payable                              $      9,242  $       9,366
  Current portion of long term debt, notes and
   working capital                                    12,146         17,966
  Mandatorily redeemable Series B convertible
   preferred stock                                     2,590          2,540
  Other current liabilities                            6,937          6,245
                                                ------------  -------------
Total current liabilities                             30,915         36,117

Total long term liabilities                           65,615         73,792

Total stockholders' deficit                           (1,083)       (12,767)

                                                ------------  -------------
Total liabilities and stockholders' deficit     $     95,447  $      97,142
                                                ============  =============




           RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME/(LOSS)
                          (unaudited, in thousands)

                             Three months ended         Six months ended
                                  June 30                   June 30
                         ------------------------- -------------------------
                             2014         2013         2014         2013
                         ------------ ------------ ------------ ------------
Net income/(loss)              $2,722     $(9,593)      $10,409    $(19,406)
Adjustments:
  Interest expense              5,032        9,216       10,185       15,117
  Income tax expense                -            -            6            6
  Intangibles and other
   amortization expense            32           20           64          144
  Depreciation expense          1,150        1,153        2,302        2,318
  Share-based-
   compensation                   159          387          290          680
                         ------------ ------------ ------------ ------------
Total adjustments               6,373       10,776       12,847       18,265
                         ------------ ------------ ------------ ------------
Adjusted EBITDA                $9,095       $1,183      $23,256     $(1,141)
                         ============ ============ ============ ============





                      PRODUCTION AND PRICE PERFORMANCE
                                 (unaudited)

                               Three months ended        Six months ended
                                     June 30                 June 30
                            ------------------------ -----------------------
                                2014        2013         2014        2013
                            ----------- ------------ ----------- -----------
Ethanol
Gallons Sold (in millions)         14.9          9.8        31.0        12.1
Average Sales Price/Gallon        $2.74        $2.88       $2.83       $2.80
WDG
Tons Sold (in thousands)          101.9         73.9       214.4        90.2
Average Sales Price/Ton            $115          $96        $106         $99

Biodiesel
Metric tons sold (in
 thousands)                         3.1         10.5         4.1        16.8
Average Sales Price/Metric
 ton                               $921         $855        $933        $847
Refined Glycerin
Metric tons sold (in
 thousands)                         0.4          1.2         1.0         2.1
Average Sales Price/Metric
 ton                               $964         $917      $1,004        $926

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.